Valproate sensitizes human glioblastoma cells to 3-bromopyruvate-induced cytotoxicity
Author:
Funder
Hokkaido University
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference32 articles.
1. Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDRI;Abe;Br. J. Cancer,1995
2. Glioblastoma multiforme: a review of where we have been and where we are going;Adamson;Expert Opin. Invest. Drugs,2009
3. The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside;Azevedo-Silva;J. Bioenerg. Biomembr..,2016
4. Monocarboxylate transporters as targets and mediators in cancer therapy response;Baltazar;Histol. Histopathol.,2014
5. MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors;Birsoy;Nat. Genet.,2013
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Related mechanisms, current treatments, and new perspectives in meningioma;Genes, Chromosomes and Cancer;2024-05
2. In vitro and in vivo evaluation of nanoliposomes loading quercetin and 3-bromopyruvate against glioma;Future Journal of Pharmaceutical Sciences;2024-01-12
3. 2-Deoxy-D-glucose increases the sensitivity of glioblastoma cells to BCNU through the regulation of glycolysis, ROS and ERS pathways: In vitro and in vivo validation;Biochemical Pharmacology;2022-05
4. Frontiers in the treatment of glioblastoma: Past, present and emerging;Advanced Drug Delivery Reviews;2021-04
5. The efficacy of the anticancer 3-bromopyruvate is potentiated by antimycin and menadione by unbalancing mitochondrial ROS production and disposal in U118 glioblastoma cells;Heliyon;2020-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3